Aclaris Therapeutics Inc (ACRS) — Financial Flexibility Index
Aclaris Therapeutics Inc (ACRS) has a Financial Flexibility Index of -0.20x as of September 2025. Free cash flow of $-10.91 Million (operating CF $-10.93 Million minus capex $23.00K) represents 0% of total liabilities ($55.43 Million). Check Aclaris Therapeutics Inc (ACRS) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Aclaris Therapeutics Inc Financial Flexibility Index (2013–2024)
Historical Financial Flexibility Index trend for Aclaris Therapeutics Inc across 12 annual periods. For the full cash flow conversion analysis, see ACRS cash flow conversion.
Annual Financial Flexibility Index for Aclaris Therapeutics Inc (2013–2024)
Year-by-year free cash flow to debt coverage for Aclaris Therapeutics Inc. Explore ACRS operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.31x | $-19.95 Million | $-20.07 Million | $64.77 Million | ▲ +83.9% |
| 2023 | -1.91x | $-77.02 Million | $-78.33 Million | $40.23 Million | ▼ -62.9% |
| 2022 | -1.18x | $-66.96 Million | $-67.57 Million | $56.98 Million | ▼ -22.2% |
| 2021 | -0.96x | $-51.83 Million | $-52.13 Million | $53.87 Million | ▲ +16.5% |
| 2020 | -1.15x | $-38.18 Million | $-38.63 Million | $33.13 Million | ▲ +65.5% |
| 2019 | -3.34x | $-94.83 Million | $-96.44 Million | $28.39 Million | ▼ -103.0% |
| 2018 | -1.65x | $-99.45 Million | $-100.81 Million | $60.44 Million | ▲ +43.8% |
| 2017 | -2.93x | $-53.43 Million | $-54.66 Million | $18.25 Million | ▲ +43.8% |
| 2016 | -5.21x | $-34.37 Million | $-34.60 Million | $6.59 Million | ▲ +59.2% |
| 2015 | -12.77x | $-19.86 Million | $-20.37 Million | $1.55 Million | ▼ -6646.9% |
| 2014 | -0.19x | $-7.22 Million | $-7.64 Million | $38.13 Million | ▲ +10.1% |
| 2013 | -0.21x | $-4.92 Million | $-4.92 Million | $23.37 Million | — |